[1] Tomaic V. Functional Roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites[J].Cancers (Basel),2016,8(10):E95.
[2] Jalal Kiani S, Shatizadeh Malekshahi S, Yousefi Ghalejoogh Z,et al. Detection and typing of human papilloma viruses by nested multiplex polymerase chain reaction assay in cervical cancer[J]. Jundishapur J Microbiol, 2015, 8(12):e26441.
[3] Burk RD, Harari A, Chen Z. Human papillomavirus genome variants[J]. Virology,2013, 445(1/2):232-243.
[4] Tommasino M. The human papillomavirus family and its role in carcinogenesis[J]. Semin Cancer Biol, 2014,26:13-21.
[5] Schiller JT, Day PM, Kines RC. Current understanding of the mechanism of HPV infection[J]. Gynecol Oncol, 2010,118(1 Suppl):S12-17.
[6] Liu YQ, He X, Xu SS, et al. Epidemiology and genotype distribution of high risk human papillomavirus in population of hospital opportunistic screening[J]. Int J Clin Exp Med,2015, 8(9):16007-16014.
[7] Denny L.Cervical cancer:prevention and treatment[J].Discov Med,2012,14(75):125-131.
[8] Pastor C, Cabello Ubeda A. Target population for the screening of human papillomavirus (HPV) and anal carcinoma precursor lesions-Results from a pilot study in HIV-infected males with sexual risk factors[J]. Rev Esp Enferm Dig, 2017, 109(4):241.
[9] Li J, Zhang TY, Tan LT, et al. Expression of human papillomavirus and prognosis of juvenile laryngeal papilloma[J]. Int J Clin Exp Med,2015, 8(9):15521-15527.
[10] Cao F, Zhang W, Zhang F, et al. Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma[J]. Int J Clin Exp Med,2014, 7(10):3430-3438.
[11] Torre LA, Bray F, Siegel RL,et al. Global cancer statistics,2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
[12] Ghittoni R, Accardi R, Chiocca S, et al. Role of human papillomaviruses in carcinogenesis[J]. Ecancermedicalscience, 2015, 9:526.
[13] Subramanian N, Chinnappan S. Prediction of promiscuous epitopes in the e6 protein of three high risk human papilloma viruses:a computational approach[J]. Asian Pac J Cancer Prev, 2013, 14(7):4167-4175.
[14] Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer[J].Cancer Epidemiol Biomarkers Prev,2013,22(4):553-560.
[15] Yang K, Xia B, Wang W, et al. A comprehensive analysis of metabolomics and transcriptomics in cervical cancer[J]. Sci Rep, 2017,7:43353.
[16] Lu H, Jiang PC, Zhang XD, et al. Characteristics of bacterial vaginosis infection in cervical lesions with high risk human papillomavirus infection[J]. Int J Clin Exp Med, 2015, 8(11):21080-21088.
[17] Mirzayans R, Andrais B, Kumar P, et al. Significance of wild-type p53 signaling in suppressing apoptosis in response to chemical genotoxic agents:Impact on chemotherapy outcome[J]. Int J Mol Sci, 2017, 18(5). E928.
[18] Shai A, Pitot HC, Lambert PF. E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice[J]. Cancer Res,2010,70(12):5064-5073.
[19] Zhang W, Che Q, Tan H, et al. Marine Streptomyces sp. derived antimycin analogues suppress HeLa cells via depletion HPV E6/E7 mediated by ROS-dependent ubiquitin-proteasome system[J]. Sci Rep, 2017,7:42180.
[20] Lagunas-Martínez A, García-Villa E, Arellano-Gaytán M, et al. MG132 plus apoptosis antigen-1(APO-1) antibody cooperate to restore p53 activity inducing autophagy and p53-dependent apoptosis in HPV16 E6-expressing keratinocytes[J]. Apoptosis, 2017,22(1):27-40.
[21] Fan X, Liu Y, Heilman SA, et al. Human papillomavirus E7 induces rereplication in response to DNA damage[J]. J Virol,2013,87(2):1200-1210.
[22] Tzenov YR, Andrews PG, Voisey K, et al. Human papilloma virus (HPV) E7-mediated attenuation of retinoblastoma (Rb) induces hPygopus2 expression via Elf-1 in cervical cancer[J]. Mol Cancer Res,2013,11(1):19-30.
[23] Zhang W, Tian Y, Chen JJ, et al. A postulated role of p130 in telomere maintenance by human papillomavirus oncoprotein E7[J]. Med Hypotheses,2012,79(2):178-180.
[24] Pang T, Wang S, Gao M, et al. HPV18 E7 induces the over-transcription of eIF4E gene in cervical cancer[J]. Iran J Basic Med Sci,2015, 18(7):684-690.
[25] Rashid NN, Rothan HA, Yusoff MS. The association of mammalian DREAM complex and HPV16 E7 proteins[J]. Am J Cancer Res, 2015,5(12):3525-3533.
[26] Nor Rashid N, Yusof R, Watson RJ. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses[J]. Acta Virol,2013,57(4):447-451.
[27] Cai Q, Lv L, Shao Q, et al. Human papillomavirus early proteins and apoptosis[J]. Arch Gynecol Obstet, 2013,287(3):541-548.
[28] McCloskey R, Menges C, Friedman A, et al. Human papillomavirus type 16 E6/E7 upregulation of nucleophosmin is important for proliferation and inhibition of differentiation[J]. J Virol,2010, 84(10):5131-5139.
[29] Bae SN, Lee KH, Kim JH, et al. Zinc induces apoptosis on cervical carcinoma cells by p53-dependent and -independent pathway[J]. Biochem Biophys Res Commun,2017,484(1):218-223.
[30] Katzenellenbogen R. Telomerase Induction in HPV Infection and Oncogenesis[J]. Viruses, 2017, 9(7). pii:E180.
[31] Dakic A, DiVito K, Fang S, et al. ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes[J]. Oncotarget,2016,7(41):66740-66753.
[32] Wu SX, Ren XY, Pan YL, et al. Effects of ALA-PDT on HPV16-immortalized cervical epithelial cell[J]. Neoplasma,2017,64(2):175-181.
[33] Jiang J, Zhao LJ, Zhao C, et al. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells[J]. Gynecol Oncol,2012,124(3):534-541.
[34] Fu Z, Tian H, Wang F, et al. Carcinogenic mechanisms of high-risk human papillomavirus oncoproteins[J]. Int J Clin Exp Med,2016,9(10):20439-20447.
[35] Yin F, Wang N, Wang S, et al. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3[J]. Oncol Rep, 2017,37(4):2324-2334.
[36] Gradíssimo A, Burk RD. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention[J]. Expert Rev Mol Diagn,2017,17(4):379-391. |
